What does DOKTER CARESSA MEERT, HEMATOLOOG do?

DOKTER CARESSA MEERT, HEMATOLOOG is a specialist medical practice in Destelbergen. Private Limited, started on 17 May 2019, 1 establishment.

What is the address of DOKTER CARESSA MEERT, HEMATOLOOG?

The registered office of DOKTER CARESSA MEERT, HEMATOLOOG is located at Bommelsrede(HEU) 52B, 9070 Destelbergen.

Is DOKTER CARESSA MEERT, HEMATOLOOG still active?

Yes. According to the CBE (18 September 2026) DOKTER CARESSA MEERT, HEMATOLOOG is active, legal situation “Normale toestand”, started on 17 May 2019.

Is DOKTER CARESSA MEERT, HEMATOLOOG registered on Peppol?

Yes, DOKTER CARESSA MEERT, HEMATOLOOG is registered on the Peppol network with ID 0208:0726852870.

What is the enterprise number of DOKTER CARESSA MEERT, HEMATOLOOG?

The enterprise number of DOKTER CARESSA MEERT, HEMATOLOOG is BE0726852870.

When was DOKTER CARESSA MEERT, HEMATOLOOG founded?

DOKTER CARESSA MEERT, HEMATOLOOG was founded on 17 May 2019.

Who are the directors of DOKTER CARESSA MEERT, HEMATOLOOG?

According to the 2025 annual accounts, the directors of DOKTER CARESSA MEERT, HEMATOLOOG are: Caressa Meert.

Is DOKTER CARESSA MEERT, HEMATOLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 May 2019; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOKTER CARESSA MEERT, HEMATOLOOG make in 2025?

DOKTER CARESSA MEERT, HEMATOLOOG posted a profit after taxes of € 238,403 in financial year 2025.

What is the revenue of DOKTER CARESSA MEERT, HEMATOLOOG?

As a small company, DOKTER CARESSA MEERT, HEMATOLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 315,757.

DOKTER CARESSA MEERT, HEMATOLOOG (Private Limited)

Dossier DOKTER CARESSA MEERT, HEMATOLOOG, printed on 18 September 2026 from databakkes.be/en/0726852870/dokter-caressa-meert-hematoloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTER CARESSA MEERT, HEMATOLOOG from Destelbergen, company number BE0726852870, closed financial year 2025 with a result of € 238,403 after tax. For that financial year DOKTER CARESSA MEERT, HEMATOLOOG recorded a gross margin of € 315,757 and equity of € 1,000. Compared with financial year 2024, the result moved from € 269,771 to € 238,403. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 16, 2025.

What it is worth Healthy

€ 1,000

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 238,403

▼ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 211,566

▼ 58% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 238,403 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 714

▼ 43% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,035

▼ 12% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 5,650

▼ 74% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 366,100 Gross margin 2022: € 366,100 First fiscal year in the series	€ 279,770 Gross margin 2023: € 279,770 ▼ 24% vs 2022 (€ 366,100) Unfavourable step	€ 366,103 Gross margin 2024: € 366,103 ▲ 31% vs 2023 (€ 279,770) Favourable step	€ 315,757 Gross margin 2025: € 315,757 ▼ 14% vs 2024 (€ 366,103) Unfavourable step	▼ 14%
Profit after taxes	€ 276,972 Profit after taxes 2022: € 276,972 First fiscal year in the series	€ 212,449 Profit after taxes 2023: € 212,449 ▼ 23% vs 2022 (€ 276,972) Unfavourable step	€ 269,771 Profit after taxes 2024: € 269,771 ▲ 27% vs 2023 (€ 212,449) Favourable step	€ 238,403 Profit after taxes 2025: € 238,403 ▼ 12% vs 2024 (€ 269,771) Unfavourable step	▼ 12%
Equity	€ 599,554 Equity 2022: € 599,554 First fiscal year in the series	€ 216,623 Equity 2023: € 216,623 ▼ 64% vs 2022 (€ 599,554) Unfavourable step	€ 1,000 Equity 2024: € 1,000 ▼ € 215,623 vs 2023 (€ 216,623) Unfavourable step	€ 1,000 Equity 2025: € 1,000 Unchanged (€ 1,000) Unchanged
Total debts	€ 107,553 Total debts 2022: € 107,553 First fiscal year in the series	€ 370,789 Total debts 2023: € 370,789 ▲ 245% vs 2022 (€ 107,553) Unfavourable step	€ 730,764 Total debts 2024: € 730,764 ▲ 97% vs 2023 (€ 370,789) Unfavourable step	€ 371,074 Total debts 2025: € 371,074 ▼ 49% vs 2024 (€ 730,764) Favourable step	▼ 49%
Cash	€ 433,431 Cash 2022: € 433,431 First fiscal year in the series	€ 440,615 Cash 2023: € 440,615 ▲ 2% vs 2022 (€ 433,431) Favourable step	€ 507,027 Cash 2024: € 507,027 ▲ 15% vs 2023 (€ 440,615) Favourable step	€ 211,566 Cash 2025: € 211,566 ▼ 58% vs 2024 (€ 507,027) Unfavourable step	▼ 58%
Retained profit	€ 598,554 Retained profit 2022: € 598,554 First fiscal year in the series	€ 215,623 Retained profit 2023: € 215,623 ▼ 64% vs 2022 (€ 598,554) Unfavourable step	€ 0 Retained profit 2024: € 0 ▼ 100% vs 2023 (€ 215,623) Unfavourable step	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 595,380 Dividend 2023: € 595,380 Unchanged (€ 0) Unchanged	€ 485,394 Dividend 2024: € 485,394 ▼ 18% vs 2023 (€ 595,380) Unchanged	€ 238,403 Dividend 2025: € 238,403 ▼ 51% vs 2024 (€ 485,394) Unchanged	▼ 51%
Balance sheet total	€ 707,108 Balance sheet total 2022: € 707,108 First fiscal year in the series	€ 587,412 Balance sheet total 2023: € 587,412 ▼ 17% vs 2022 (€ 707,108) Unchanged	€ 731,764 Balance sheet total 2024: € 731,764 ▲ 25% vs 2023 (€ 587,412) Unchanged	€ 372,074 Balance sheet total 2025: € 372,074 ▼ 49% vs 2024 (€ 731,764) Unchanged	▼ 49%

Key figures of DOKTER CARESSA MEERT, HEMATOLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DOKTER CARESSA MEERT, HEMATOLOOG?

What happened at DOKTER CARESSA MEERT, HEMATOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 16, 2025 New annual accounts for financial year 2025: profit of € 238,403 (▼ 12% vs 2024). Source: NBB ↗
May 17, 2019 New establishment in Destelbergen. KBO
May 17, 2019 Start of the company according to the CBE. KBO
2019 Caressa Meert became a director. NBB

In short

From € 276,972 profit in 2022 to € 238,403 profit in 2025.

Paid € 313,498 in corporate taxes since 2022.

Best year ever: 2022, with € 276,972 profit.

Paid out € 1.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER CARESSA MEERT, HEMATOLOOG? We notify you, reason included.

Follow DOKTER CARESSA MEERT, HEMATOLOOG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Caressa Meert

DOKTER CARESSA MEERT, HEMATOLOOG

Behind DOKTER CARESSA MEERT, HEMATOLOOG is Caressa Meert.

See the full network in the app

Directors

According to the 2025 annual accounts

Caressa Meert

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Bommelsrede(HEU) 52B

9070 Destelbergen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0726.852.870
VAT number: BE 0726.852.870
Registered office: Bommelsrede(HEU) 52B, 9070 Destelbergen
Names & denominations: DOKTER CARESSA MEERT, HEMATOLOOG
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 May 2019
Peppol: Active · Active since 24 Nov 2023
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗